Approval · Notice of Compliance 2490 · 2001
TRILEPTAL: Notice of Compliance 2490
Issued October 12, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2490
- Date
- October 12, 2001
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Anti-epileptic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRILEPTAL | 02244673 | Marketed |
Medicinal ingredients
- OXCARBAZEPINE 60 MG per ML